36 results
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... for Preventing ... Penicilliosis #IDSA ... #Prevention #Treatment ... #management #opportunistic
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
Diagnosis and Management ... Perforation) Pathophysiology ... Epidemiology: • #1 ... 10 mg/kg IV x 1 ... IDSA 2021 CDI
IDSA Surgical Wound Infection Algorithm
Algorithm for the management and treatment of surgical site infections (SSIs). 
*For
IDSA Surgical Wound ... the management and ... treatment of surgical ... patients with type 1 ... #IDSA #management
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... screen within 1 ... 0.5mL IM at 0, 1– ... #Prevention #Treatment ... #management #opportunistic
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... difficile Infection (CDI ... Enteric #Bacterial #IDSA ... #Prevention #Treatment ... #management #opportunistic
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
IDSA Recommendations ... for Preventing ... patients with CD4 ... #Prevention #Treatment ... infections #HIVAIDS #management
Anaphylaxis: Treatments (Acute)
Additional Info:
 • IV steroids may be considered for prevention of late phase reactions.
Anaphylaxis: Treatments ... considered for prevention ... Treatment: • ... ) 1:1000 IM q5-10mins ... #Management #pathophysiology
Polycythemia Vera (PV) - Diagnosis and Management Summary
Diagnostic Criteria:
 • Elevated hemoglobin and/or hematocrit AND
 •
Diagnosis and Management ... erythropoietin 1/ ... incidentally via CBC ... of symptoms and prevention ... • Treatment algorithms
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
IDSA Recommendations ... mg/kg on days 1– ... leishmaniasis and CD4 ... Leishmaniasis #Prevention ... #Treatment #management
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... 4–6 mL QID or 1– ... candida #mucosal #IDSA ... #Prevention #Treatment ... #management #opportunistic